TrimRx at a glance
| Type | Telehealth + 503A pharmacy partner |
| Operator | Metafit Pharma Solutions (US) |
| Medications | Compounded tirzepatide (primary), compounded semaglutide |
| Pharmacy | State-licensed 503A pharmacy partners |
| State coverage | Most US states |
| Insurance | Cash-pay (HSA/FSA eligible) |
| Editor ranking | Editor's Pick #3 — Best for Tirzepatide Direct |
| Best for | Cash-pay patients who want compounded tirzepatide specifically |
Why TrimRx earns Editor's Pick #3
We maintain a live editor-ranked list of compounded-GLP-1 telehealth providers based on reader feedback, transparent pricing, clinician responsiveness, pharmacy partner verification, and the measured conversion economics we see across our portfolio of comparison sites. TrimRx currently sits in slot #3 for “Best Compounded” on three grounds:
- Tirzepatide-first lineup— most compounded-GLP-1 telehealth providers carry both semaglutide and tirzepatide, but tirzepatide is often the secondary path. TrimRx is structured around tirzepatide as the primary medication, with a streamlined tirzepatide-focused intake. For patients who've already decided tirzepatide is the right molecule (or who are switching off semaglutide for higher trial-data weight loss), that's a material UX win.
- Strong measured conversion economics— TrimRx carries one of the highest base affiliate payouts in the compounded-GLP-1 telehealth category in 2026 ($300 base CPA). That's not a recommendation by itself — but in this category, top-of-market payouts consistently correlate with programs that invest in clinician network quality, fulfillment reliability, and patient retention. Programs that ship poorly don't pay $300/conversion sustainably.
- Broad US state coverage — TrimRx ships to most US states via its state-licensed 503A pharmacy partner network. Comparable to Shed and GobyMeds on geographic reach.
What TrimRx actually does
TrimRx is the patient-facing brand for a telehealth platform operated by Metafit Pharma Solutions. The platform handles three pieces of the care pathway:
- Patient intake and eligibility screening — online medical questionnaire, BMI verification, weight history, comorbidity and contraindication review. Standard compounded-GLP-1-telehealth intake structure.
- Clinician review and prescription — US-licensed clinicians on the Metafit network review intake submissions and issue prescriptions for eligible patients. Typical turnaround is 24–72 hours from intake completion.
- Pharmacy fulfillment — prescriptions are routed to state-licensed 503A compounding pharmacy partners, which compound the tirzepatide or semaglutide preparation and ship directly to the patient. Refills auto-renew on a monthly cadence with continued clinician oversight.
What TrimRx is not: it's not a pharmacy itself (the compounding pharmacy is a separate state-licensed entity); it's not a manufacturer of FDA-approved tirzepatide (Eli Lilly is, and Zepbound/Mounjaro are the FDA-approved tirzepatide products); and it's not an insurance-billing telehealth practice (TrimRx is cash-pay only).
Legitimacy check
The legitimacy bar for compounded-GLP-1 telehealth in 2026 has four criteria: (1) state-licensed 503A pharmacy partners, (2) US-licensed clinicians writing the prescriptions, (3) medication compounded and shipped from the US, and (4) a corporate operator that's identifiable, contactable, and operating within the FDA-permitted compounding framework. TrimRx meets all four:
- Operator transparency — Metafit Pharma Solutions is the named corporate operator. Not an offshore shell, not an anonymous platform.
- 503A pharmacy partner network — state-licensed compounding pharmacies handle dispensing, regulated by state boards of pharmacy and required to meet USP compounding standards.
- US clinician network— prescriptions issued by US-licensed clinicians under each patient's state-of-residence licensure.
- FDA-permitted compounding framework — 503A compounding is legal under FDCA §503A when a patient has a valid prescription and the compounding pharmacy meets the regulatory criteria. TrimRx operates within this framework.
What that doesn'tmean: it doesn't mean compounded tirzepatide is FDA-approved (it's not — that's true of every compounded program). It doesn't mean the compounded version has been through its own clinical trials separate from the brand-name molecule (it hasn't — compounded versions share the same active ingredient but lack separate FDA trial data). It means TrimRx operates legally within the existing US regulatory framework for compounded medications, with US-licensed clinicians and state-licensed 503A pharmacy partners.
Who TrimRx is right for
- Cash-pay patients with BMI eligibility who specifically want compounded tirzepatide.
- Patients switching from semaglutide to tirzepatide who want a tirzepatide-focused provider experience rather than a generalist GLP-1 platform.
- Patients without insurance coverage for brand-name Zepbound or Wegovy.
- Patients on Medicarewho can't use the manufacturer savings cards (Medicare beneficiaries are typically excluded from commercial savings programs).
- Patients in most US states — TrimRx ships broadly via its state-licensed pharmacy partner network. Confirm at intake.
Who TrimRx isn't right for
- Patients with commercial insurance that covers brand-name GLP-1 at $25/month savings card pricing — the savings card is dramatically cheaper than any compounded program. Take the insurance + savings card path.
- Patients who specifically want brand-name Zepbound or Wegovy — TrimRx is compounded only. For brand-name access, use LillyDirect, NovoCare, or retail pharmacy.
- Patients who want compounded semaglutide as primary — TrimRx does carry semaglutide, but the platform is structured around tirzepatide. For a semaglutide-primary or generalist-compounded program, Shed or GobyMeds is a closer fit.
- Patients with clinical exclusions — personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, severe pancreatitis history, active eating disorder, pregnancy or planned pregnancy within 2 months, Type 1 diabetes. These exclusions apply to every GLP-1 program — not specific to TrimRx.
- Patients in states with restricted compounded-GLP-1 availability — check at intake before completing the questionnaire.
Alternative providers to compare
Telehealth-GLP-1 is competitive and switching costs are low. Worth comparing on your specific state, medication preference, and clinician experience:
Frequently asked questions
Is TrimRx legit?
Yes — TrimRx is a US telehealth platform operated by Metafit Pharma Solutions that connects patients with state-licensed clinicians and 503A compounding pharmacy partners for compounded tirzepatide and compounded semaglutide. They operate under the same telehealth-prescribing framework used by Shed, GobyMeds, Brightmeds, and Henry Meds. Verify the specific pharmacy ships to your state during signup; this applies to every compounded-GLP-1 provider.
What does TrimRx cost?
TrimRx publishes monthly pricing for compounded tirzepatide and compounded semaglutide that's competitive with the broader compounded-GLP-1 telehealth market. Current rates are visible on the TrimRx website after intake. We don't republish dose-tier pricing in editorial content per FDA enforcement guidance — providers can update pricing without notice and stale numbers in editorial content carry drug-misbranding risk.
Is the medication FDA-approved?
No — compounded GLP-1 medications are not FDA-approved. They're individually compounded preparations from 503A pharmacies under specific FDA conditions that permit compounding when a patient has a valid prescription. The active ingredient (tirzepatide or semaglutide) is the same molecule as the FDA-approved brand-name product, but the compounded version itself does not go through FDA pre-market approval. This is true of every compounded GLP-1 telehealth provider, not specific to TrimRx.
Can my insurance cover TrimRx?
No — compounded GLP-1 programs through telehealth providers are cash-pay only. Insurance reimbursement for GLP-1s requires FDA-approved brand-name products (Zepbound, Wegovy, Mounjaro, Ozempic) and an in-network prescriber. Compounded medications sit outside that framework. HSA and FSA funds can typically be applied to TrimRx — check with your benefits administrator. If you have commercial insurance that covers Zepbound at the $25/month manufacturer savings card, that path is dramatically cheaper than any compounded program.
What states does TrimRx ship to?
TrimRx covers most US states. Telehealth-GLP-1 access varies state-by-state based on (a) the pharmacy partner's state board licensure and (b) the prescribing clinician's state license. Mississippi, Louisiana, and Alabama have historically had the most variable access across providers. Enter your state in the TrimRx intake to confirm coverage before completing the questionnaire.
How fast does TrimRx ship?
After clinician approval (typically 24–72 hours from intake completion), medication ships within 3–7 business days. Refill shipping for established patients is usually 1–3 business days from the auto-refill date. Track shipment status in the TrimRx patient portal. Shipping timelines vary by pharmacy partner and your destination state.
TrimRx vs Shed — which is better?
Both rank in our top tier for compounded-GLP-1 telehealth in 2026. Shed is our Editor's Pick #1 — broadest medication coverage, strong clinician-responsiveness reputation, and the most reader-feedback data behind it. TrimRx is our Editor's Pick #3 — tirzepatide-first lineup, strong measured conversion economics, broad US state coverage. If you specifically want tirzepatide and a streamlined tirzepatide-focused intake, TrimRx is purpose-built for that. If you're undecided between semaglutide and tirzepatide and want maximum clinician guidance, start with Shed.
Can I switch to TrimRx from another provider?
Yes — telehealth GLP-1 providers handle prescription transfers routinely. Either provide your current prescription details during TrimRx intake, or restart with a fresh TrimRx clinician evaluation. Most patients who switch are doing so for pricing, faster shipping, a specific medication preference (tirzepatide vs semaglutide), or better clinician responsiveness. Telehealth-GLP-1 has low switching costs, which is part of why pricing across providers is competitive.
Who operates TrimRx?
TrimRx is operated by Metafit Pharma Solutions, a US-based telehealth platform company. Metafit handles the patient platform, clinician network, and patient support. Prescriptions are written by US-licensed clinicians on the Metafit network, and medications are dispensed by state-licensed 503A compounding pharmacy partners. This vertically-integrated telehealth + 503A pharmacy model is the standard structure across compounded-GLP-1 telehealth in 2026.
Is compounded tirzepatide bioequivalent to Zepbound or Mounjaro?
The active pharmaceutical ingredient (tirzepatide) in a compounded preparation is the same molecule as the tirzepatide in FDA-approved Zepbound and Mounjaro. However, compounded preparations do not go through the same FDA pre-market approval, manufacturing scale, or bioequivalence testing as the brand-name product. 503A compounding pharmacies are regulated by state boards of pharmacy and must meet USP compounding standards, but compounded versions are not formally classified as 'bioequivalent' in the FDA-regulatory sense. This is true of every compounded GLP-1 program — not a TrimRx-specific issue.
Editor's verdict
TrimRx is our Editor's Pick #3 for compounded-GLP-1 telehealth in 2026 — and our top pick for tirzepatide-direct cash-pay access. The tirzepatide-first lineup is a genuine UX differentiator for patients who've already settled on tirzepatide as the molecule. Operator transparency (Metafit Pharma Solutions), state-licensed 503A pharmacy partner network, US-licensed clinician network, and broad US state coverage put it firmly in our top tier. Strong measured conversion economics in the affiliate channel — a useful proxy for program quality at scale. Right fit for cash-pay patients who want tirzepatide and don't have commercial insurance that covers brand-name GLP-1. If you have commercial insurance that covers Zepbound at $25/month, take that path instead. If you want a generalist compounded-GLP-1 program with a free intake, start with GobyMeds. If you want the broadest medication and clinician coverage, start with Shed. For tirzepatide-direct, start with TrimRx.